Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.

Journal of virology - 24 Feb 2021

Lee Eunok, Sandgren Kerrie, Duette Gabriel, Stylianou Vicki V, Khanna Rajiv, Eden John-Sebastian, Blyth Emily, Gottlieb David, Cunningham Anthony L, Palmer Sarah

Abstract excerpt

Developing optimal T-cell response assays to severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is critical for measuring the duration of immunity to this disease and assessing the efficacy of vaccine candidates. These assays need to target conserved regions of SARS-CoV-2 global variants and avoid cross-reactivity to seasonal human coronaviruses. To contribute to this effort, we employed an in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronavirus

Share to Coronavirus Nucleocapsid Proteins

Share to Epitopes, T-Lymphocyte

Share to Immunity, Cellular

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33443088
DOI: 10.1128/JVI.02002-20
PMCID: PMC8579755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.PMID 33443088Read ↗

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validationSemantic proximity Read ↗

Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike proteinSemantic proximity Read ↗

Identification of promising SARS-CoV-2 CD8+ and CD4+ T cell epitopes by immunoinformatics approach for a multi-epitope-based vaccine designSemantic proximity Read ↗

Identification of a Promiscuous Conserved CTL Epitope Within the SARS-CoV-2 Spike ProteinSemantic proximity Read ↗

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine TargetsSemantic proximity Read ↗

COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2Semantic proximity Read ↗

An Immunoinformatic Approach for Identifying and Designing Conserved Multi-Epitope Vaccines for CoronavirusesSemantic proximity Read ↗

Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics ApproachesSemantic proximity Read ↗

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.Semantic proximity Read ↗

The T cell epitope landscape of SARS-CoV-2 variants of concernSemantic proximity Read ↗

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individualsSemantic proximity Read ↗

Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine DesignSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.